NCT03043469

Brief Summary

Dysfunctional breathing (DB) is a respiratory condition characterised by an abnormal breathing pattern, among other complaints, that can occur either in the absence of other pathophysiology (primary DB), e.g. anxiety-related factors, or secondary to cardiopulmonary disease (secondary DB), e.g. asthma. As a consequence, patients may experience breathlessness and present with periods of increased ventilation or erratic breathing, interspersed with episodes of breath holding or deep sighs. In addition to respiratory symptoms, DB also generates non- respiratory symptoms (e.g. dizziness and increased heart rate). It is estimated 1 in 10 people in the United Kingdom (UK) have DB. However, DB remains poorly understood, with no standardised approach to diagnosis and assessment. The purposes of this study are: Study 1) To identify physiological, functional and psychological characteristics of participants with DB compared to healthy participants. Firstly, symptoms, lung function, respiratory gas analysis, exercise capacity, respiratory muscle function, respiratory motion, level of physical activity, quality of life and anxiety \& depression scores will be assessed in 20 participants with primary DB, 20 with secondary DB and compared to 20 healthy participants. Study 2) To develop an assessment tool based on physiological, functional or psychological variables found to be different between any of the 3 groups in Study 1. In order to do that, 54 people with DB (between primary and secondary) and 27 people presenting with breathlessness secondary to restrictive lung disease will be assessed. Analysis of these data will determine whether these variables can be used as a diagnostic tool capable of distinguishing DB from restrictive lung diseases characterised by breathlessness. The recruitment period will be 1-2 years, with an individual participation of 9 days; 1-day on site testing, plus 7-day home activity monitoring, and 1 day to return the activity monitor (which will happen whenever the participant needs to return to the site).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
141

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 6, 2017

Completed
3.5 years until next milestone

Study Start

First participant enrolled

August 8, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
Last Updated

July 8, 2020

Status Verified

July 1, 2020

Enrollment Period

9 months

First QC Date

January 30, 2017

Last Update Submit

July 7, 2020

Conditions

Keywords

dysfunctional breathing

Outcome Measures

Primary Outcomes (5)

  • Signs of Anxiety and Depression

    Anxiety and depression will be evaluated by the widely used Hospital Anxiety and Depression Scale (HADS), developed by Zigmond and Snaith (1983) to identify and screen cases of anxiety and depression in non-psychiatric environments. It has been proven to be a valid psychological instrument (Bjelland et al. 2002). The HADS is subdivided into two subscales with seven questions each: Anxiety (HADS-A) and Depression (HADS-B). Therefore, it is able to differentiate anxiety from depression possible/probable disorders.

    This scale will be applied only once during the first day of assessment and takes about 5 minutes for the participant to complete.

  • Levels of subjective sensation related to Hyperventilation Syndrome

    The Nijmegen Questionnaire is a clinically used tool for analysis of 16 symptoms related to Hyperventilation syndrome arising from different body systems (such as chest pain, blurred vision and faster or deeper breathing). The participant will choose the answer from a 5-point ordinal scale considering the frequency of symptoms. 23 of 64 points or more is considered positive for abnormality of subjective sensations (van Dixhoorn and Folgering 2015) and correlates positively with Dysfunctional Breathing (Vansteenkiste, Rochette, Demedt, 1991).

    This scale will be applied only once and takes about 5 minutes to be completed by the participant.

  • Self-evaluation of breathing

    The Self Evaluation Breathing Questionnaire is a reliable tool developed by Courtney and Greenwood (2009) to assess breathing pattern of participants with Dysfunctional Breathing (Mitchell et al. 2015). It contains 17 items that are answered using a 4-point Likert scale and includes two main factors: "lack of air", which is about feeling and sensing; and "perception of inappropriate or restricted breathing", which is about observing or noticing. It has been indicated that the higher the SEBQ score, the more severe is the clinical condition of Dysfunctional Breathing (Mitchell et al. 2015). However, researchers who created the SEBQ questionnaire suggested that it can be used as a screening tool for identifying Dysfunctional Breathing and for monitoring changes in breathing symptoms after treatment, but there is no normal value available in the literature for this questionnaire yet (Courtney, Greenwood, et al. 2011).

    This scale will be applied only once and takes about 5 minutes to be completed by the participant..

  • Respiratory Motion

    The Manual Assessment of Respiratory Motion (MARM) will be used to assess thoracic and diaphragmatic movements during breathing and quantify their contribution as a percentage of the total breathing movement. During this evaluation, the examiner will position their open hands between posterior and lateral lower rib cage (lower four to six ribs) and the thumbs will vertically be positioned about 1 inch from the spine. In this position, it is possible for the examiner to identify lateral and vertical movements during breathing, as well as upper or lower rib cage predominance. The examiner will draw an upper, lower and horizontal lines starting from the centre of a circle, building a pie chart with the degree of expansion (Courtney et al. 2008, Courtney and van Dixhoorn 2014). A perfect balance between thoracic and abdominal motion during breathing presents a MARM between 0 and 6; as well as a value above 30 may be considered as dysfunctional (Courtney et al. 2011; Courtney et al. 2008).

    This assessment will be applied only once and takes about 10 minutes to be completed.

  • Breath-holding time

    In the Breath-hold test, the variable considered is the total time the participant is able to hold a breath after a normal exhalation at functional residual capacity. This standardized protocol used in participants with DB is called the Buteyko Method of the Control Pause, where the breath is held and timed until the first involuntary motion of the respiratory muscles (Courtney and Cohen 2008). The breath-holding time has been estimated to be approximately 20 seconds patients with DB, while in healthy people is approximately 60 seconds (Jack et al. 2004, Courtney and Cohen 2008). Three attempts will be undertaken with 5-minute rest in between; a stopwatch will be used to time each one, as well as the intervals. The mean of the three attempts will be analysed, in order to remove any learnt effect (Courtney, Greenwood, et al. 2011).

    This assessment will be applied only once and takes about 20 minutes to be completed.

Secondary Outcomes (25)

  • Medical History

    This assessment will be applied during the 3-hour assessment, and takes about 5 minutes to be completed.

  • Age

    This assessment will be applied during the 3-hour assessment, and takes about 20 seconds to be completed.

  • Gender

    This assessment will be applied during the 3-hour assessment, and takes about 10 seconds to be completed.

  • Weight

    This assessment will be applied during the 3-hour assessment, and takes about 10 seconds to be completed.

  • Height

    This assessment will be applied during the 3-hour assessment, and takes about 10 seconds to be completed.

  • +20 more secondary outcomes

Study Arms (4)

Healthy participants

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment. Days 2-8: Physical Activity Monitoring

Other: Short-form survey instrumentOther: Demographic dataOther: Hospital Anxiety and Depression ScaleOther: Nijmegen questionnaireOther: The Self-evaluation of breathing questionnaireOther: six-minute exercise testOther: Indirect calorimetryOther: Oxygen saturation monitoringOther: Heart rate variability analysisOther: Continuous measurement of arterial blood pressureDiagnostic Test: Lung function testOther: Respiratory muscle functionOther: Manual assessment of respiratory motionOther: Breath-hold testOther: Physical Activity monitoring

Restrictive lung disease group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment. Days 2-8: Physical Activity Monitoring

Other: Short-form survey instrumentOther: Demographic dataOther: Hospital Anxiety and Depression ScaleOther: Nijmegen questionnaireOther: The Self-evaluation of breathing questionnaireOther: six-minute exercise testOther: Indirect calorimetryOther: Oxygen saturation monitoringOther: Heart rate variability analysisOther: Continuous measurement of arterial blood pressureDiagnostic Test: Lung function testOther: Respiratory muscle functionOther: Manual assessment of respiratory motionOther: Breath-hold testOther: Physical Activity monitoring

Primary dysfunctional Breathing group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment. Days 2-8: Physical Activity Monitoring

Other: Short-form survey instrumentOther: Demographic dataOther: Hospital Anxiety and Depression ScaleOther: Nijmegen questionnaireOther: The Self-evaluation of breathing questionnaireOther: six-minute exercise testOther: Indirect calorimetryOther: Oxygen saturation monitoringOther: Heart rate variability analysisOther: Continuous measurement of arterial blood pressureDiagnostic Test: Lung function testOther: Respiratory muscle functionOther: Manual assessment of respiratory motionOther: Breath-hold testOther: Physical Activity monitoring

Secondary dysfunctional breathing group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, Asthma Control Questionnaire, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment. Days 2-8: Physical Activity Monitoring

Other: Short-form survey instrumentOther: Demographic dataOther: Hospital Anxiety and Depression ScaleOther: Nijmegen questionnaireOther: The Self-evaluation of breathing questionnaireOther: six-minute exercise testOther: Indirect calorimetryOther: Oxygen saturation monitoringOther: Heart rate variability analysisOther: Continuous measurement of arterial blood pressureDiagnostic Test: Lung function testOther: Respiratory muscle functionOther: Manual assessment of respiratory motionOther: Breath-hold testOther: Physical Activity monitoringOther: Asthma Control Questionnaire

Interventions

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Also known as: SF-36
Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Also known as: height, weight, age, gender
Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Also known as: anxiety and depression questionnaire
Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Also known as: gas analysis
Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group
Lung function testDIAGNOSTIC_TEST

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Holding the breath a few times for as long as possible.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Healthy participantsPrimary dysfunctional Breathing groupRestrictive lung disease groupSecondary dysfunctional breathing group

Only for asthmatics: answering questions about the control the participant has over this respiratory condition/symptoms.

Secondary dysfunctional breathing group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with primary/secondary dysfunctional breathing and patients with restrictive lung diseases will be recruited from clinics of respiratory medicine (secondary care). Healthy participants will be recruited from the general population (at Brunel University London).

You may qualify if:

  • patients with DB (according to the CD)
  • healthy people
  • aged 18 or over,
  • must be able to comprehend and/or perform the procedures of this research
  • must be able to consent to participate
  • people with signs of breathlessness secondary to restrictive lung disease (DB excluded)

You may not qualify if:

  • people whose condition is unstable or have experienced an exacerbation of symptoms over the last 4 weeks
  • patients who are oxygen-dependant (at rest or during exercise),
  • those who are on oral steroids or have completed a course of those medications less than four weeks prior to the assessment day,
  • those who have major orthopaedic, neurological or cardiac conditions
  • those who received breathing retraining before

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brunel University London

London, Middlesex, UB83PH, United Kingdom

Location

Related Publications (64)

  • Barker N, Everard ML. Getting to grips with 'dysfunctional breathing'. Paediatr Respir Rev. 2015 Jan;16(1):53-61. doi: 10.1016/j.prrv.2014.10.001. Epub 2014 Nov 25.

    PMID: 25499573BACKGROUND
  • Barker NJ, Jones M, O'Connell NE, Everard ML. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in children. Cochrane Database Syst Rev. 2013 Dec 18;2013(12):CD010376. doi: 10.1002/14651858.CD010376.pub2.

    PMID: 24347088BACKGROUND
  • Bott J, Blumenthal S, Buxton M, Ellum S, Falconer C, Garrod R, Harvey A, Hughes T, Lincoln M, Mikelsons C, Potter C, Pryor J, Rimington L, Sinfield F, Thompson C, Vaughn P, White J; British Thoracic Society Physiotherapy Guideline Development Group. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009 May;64 Suppl 1:i1-51. doi: 10.1136/thx.2008.110726. No abstract available.

    PMID: 19406863BACKGROUND
  • Brashear RE. Hyperventilation syndrome. Lung. 1983;161(5):257-73. doi: 10.1007/BF02713872. No abstract available.

    PMID: 6138480BACKGROUND
  • Courtney R, Greenwood KM, Cohen M. Relationships between measures of dysfunctional breathing in a population with concerns about their breathing. J Bodyw Mov Ther. 2011 Jan;15(1):24-34. doi: 10.1016/j.jbmt.2010.06.004. Epub 2010 Jul 16.

    PMID: 21147415BACKGROUND
  • Gridina I, Bidat E, Chevallier B, Stheneur C. [Prevalence of chronic hyperventilation syndrome in children and teenagers]. Arch Pediatr. 2013 Mar;20(3):265-8. doi: 10.1016/j.arcped.2012.12.016. Epub 2013 Feb 1. French.

    PMID: 23375424BACKGROUND
  • de Groot EP, Duiverman EJ, Brand PL. Dysfunctional breathing in children with asthma: a rare but relevant comorbidity. Eur Respir J. 2013 May;41(5):1068-73. doi: 10.1183/09031936.00130212. Epub 2012 Sep 27.

    PMID: 23018913BACKGROUND
  • Hagman C, Janson C, Emtner M. A comparison between patients with dysfunctional breathing and patients with asthma. Clin Respir J. 2008 Apr;2(2):86-91. doi: 10.1111/j.1752-699X.2007.00036.x.

    PMID: 20298312BACKGROUND
  • Hagman C, Janson C, Emtner M. Breathing retraining - a five-year follow-up of patients with dysfunctional breathing. Respir Med. 2011 Aug;105(8):1153-9. doi: 10.1016/j.rmed.2011.03.006. Epub 2011 Mar 31.

    PMID: 21454062BACKGROUND
  • Howell JB. The hyperventilation syndrome: a syndrome under threat? Thorax. 1997 Aug;52 Suppl 3(Suppl 3):S30-4. doi: 10.1136/thx.52.2008.s30. No abstract available.

    PMID: 9381424BACKGROUND
  • Jones M, Harvey A, Marston L, O'Connell NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009041. doi: 10.1002/14651858.CD009041.pub2.

    PMID: 23728685BACKGROUND
  • Jones M, Troup F, Nugus J, Roughton M, Hodson M, Rayner C, Bowen F, Pryor J. Does manual therapy provide additional benefit to breathing retraining in the management of dysfunctional breathing? A randomised controlled trial. Disabil Rehabil. 2015;37(9):763-70. doi: 10.3109/09638288.2014.941020. Epub 2014 Jul 15.

    PMID: 25026508BACKGROUND
  • LEWIS BI. Hyperventilation syndrome: a clinical and physiological evaluation. Calif Med. 1959 Sep;91(3):121-6.

    PMID: 14416492BACKGROUND
  • Magarian GJ. Hyperventilation syndromes: infrequently recognized common expressions of anxiety and stress. Medicine (Baltimore). 1982 Jul;61(4):219-36. No abstract available.

    PMID: 7045570BACKGROUND
  • Morgan MD. Dysfunctional breathing in asthma: is it common, identifiable and correctable? Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II31-II35. No abstract available.

    PMID: 12364708BACKGROUND
  • Peroni DG, Piacentini GL, Bodini A, Boner AL. Childhood Asthma Control Test in asthmatic children with dysfunctional breathing. J Allergy Clin Immunol. 2008 Jan;121(1):266-7; author reply 267. doi: 10.1016/j.jaci.2007.06.049. Epub 2007 Oct 17. No abstract available.

    PMID: 17920668BACKGROUND
  • Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ. 2001 May 5;322(7294):1098-100. doi: 10.1136/bmj.322.7294.1098.

    PMID: 11337441BACKGROUND
  • Thomas M, McKinley RK, Freeman E, Foy C, Price D. The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J. 2005 Apr;14(2):78-82. doi: 10.1016/j.pcrj.2004.10.007.

    PMID: 16701702BACKGROUND
  • van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29(2):199-206. doi: 10.1016/0022-3999(85)90042-x.

    PMID: 4009520BACKGROUND
  • van Dixhoorn J, Folgering H. The Nijmegen Questionnaire and dysfunctional breathing. ERJ Open Res. 2015 May 15;1(1):00001-2015. doi: 10.1183/23120541.00001-2015. eCollection 2015 May.

    PMID: 27730128BACKGROUND
  • Vansteenkiste J, Rochette F, Demedts M. Diagnostic tests of hyperventilation syndrome. Eur Respir J. 1991 Apr;4(4):393-9.

    PMID: 1855568BACKGROUND
  • Aadland E, Ylvisaker E. Reliability of the Actigraph GT3X+ Accelerometer in Adults under Free-Living Conditions. PLoS One. 2015 Aug 14;10(8):e0134606. doi: 10.1371/journal.pone.0134606. eCollection 2015.

    PMID: 26274586BACKGROUND
  • ASTRAND PO, RYHMING I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954 Sep;7(2):218-21. doi: 10.1152/jappl.1954.7.2.218. No abstract available.

    PMID: 13211501BACKGROUND
  • Bernardi L, Porta C, Gabutti A, Spicuzza L, Sleight P. Modulatory effects of respiration. Auton Neurosci. 2001 Jul 20;90(1-2):47-56. doi: 10.1016/S1566-0702(01)00267-3.

    PMID: 11485292BACKGROUND
  • Bernardi L, Wdowczyk-Szulc J, Valenti C, Castoldi S, Passino C, Spadacini G, Sleight P. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol. 2000 May;35(6):1462-9. doi: 10.1016/s0735-1097(00)00595-7.

    PMID: 10807448BACKGROUND
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3.

    PMID: 11832252BACKGROUND
  • Bogert LW, van Lieshout JJ. Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger. Exp Physiol. 2005 Jul;90(4):437-46. doi: 10.1113/expphysiol.2005.030262. Epub 2005 Mar 31.

    PMID: 15802289BACKGROUND
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.

    PMID: 7154893BACKGROUND
  • Brijker F, van den Elshout FJ, Heijdra YF, Bosch FH, Folgering HT. Effect of acute metabolic acid/base shifts on the human airway calibre. Respir Physiol. 2001 Jan;124(2):151-8. doi: 10.1016/s0034-5687(00)00196-1.

    PMID: 11164206BACKGROUND
  • Combes P, Fauvage B. Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study. Eur J Clin Pharmacol. 1997;51(5):385-8. doi: 10.1007/s002280050218.

    PMID: 9049579BACKGROUND
  • Courtney R, Cohen M. Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathing. J Altern Complement Med. 2008 Mar;14(2):115-23. doi: 10.1089/acm.2007.7204.

    PMID: 18315509BACKGROUND
  • Courtney R, van Dixhoorn J, Cohen M. Evaluation of breathing pattern: comparison of a Manual Assessment of Respiratory Motion (MARM) and respiratory induction plethysmography. Appl Psychophysiol Biofeedback. 2008 Jun;33(2):91-100. doi: 10.1007/s10484-008-9052-3. Epub 2008 Mar 5.

    PMID: 18320303BACKGROUND
  • Courtney R, van Dixhoorn J, Greenwood KM, Anthonissen EL. Medically unexplained dyspnea: partly moderated by dysfunctional (thoracic dominant) breathing pattern. J Asthma. 2011 Apr;48(3):259-65. doi: 10.3109/02770903.2011.554942. Epub 2011 Feb 22.

    PMID: 21341969BACKGROUND
  • Guelen I, Westerhof BE, Van Der Sar GL, Van Montfrans GA, Kiemeneij F, Wesseling KH, Bos WJ. Finometer, finger pressure measurements with the possibility to reconstruct brachial pressure. Blood Press Monit. 2003 Feb;8(1):27-30. doi: 10.1097/00126097-200302000-00006.

    PMID: 12604933BACKGROUND
  • Han JN, Stegen K, Simkens K, Cauberghs M, Schepers R, Van den Bergh O, Clement J, Van de Woestijne KP. Unsteadiness of breathing in patients with hyperventilation syndrome and anxiety disorders. Eur Respir J. 1997 Jan;10(1):167-76. doi: 10.1183/09031936.97.10010167.

    PMID: 9032511BACKGROUND
  • Hawkes EZ, Nowicky AV, McConnell AK. Diaphragm and intercostal surface EMG and muscle performance after acute inspiratory muscle loading. Respir Physiol Neurobiol. 2007 Mar 15;155(3):213-9. doi: 10.1016/j.resp.2006.06.002. Epub 2006 Jul 18.

    PMID: 16846758BACKGROUND
  • Healy GN, Clark BK, Winkler EA, Gardiner PA, Brown WJ, Matthews CE. Measurement of adults' sedentary time in population-based studies. Am J Prev Med. 2011 Aug;41(2):216-27. doi: 10.1016/j.amepre.2011.05.005.

    PMID: 21767730BACKGROUND
  • Homma I, Masaoka Y. Breathing rhythms and emotions. Exp Physiol. 2008 Sep;93(9):1011-21. doi: 10.1113/expphysiol.2008.042424. Epub 2008 May 16.

    PMID: 18487316BACKGROUND
  • Imholz BP, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res. 1998 Jun;38(3):605-16. doi: 10.1016/s0008-6363(98)00067-4.

    PMID: 9747429BACKGROUND
  • Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ. Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation. Am J Respir Crit Care Med. 2004 Jul 15;170(2):118-25. doi: 10.1164/rccm.200207-720OC. Epub 2004 Apr 1.

    PMID: 15059786BACKGROUND
  • Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health. 1999 Jan;53(1):46-50. doi: 10.1136/jech.53.1.46.

    PMID: 10326053BACKGROUND
  • Joseph CN, Porta C, Casucci G, Casiraghi N, Maffeis M, Rossi M, Bernardi L. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension. 2005 Oct;46(4):714-8. doi: 10.1161/01.HYP.0000179581.68566.7d. Epub 2005 Aug 29.

    PMID: 16129818BACKGROUND
  • Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999 Oct;14(4):902-7. doi: 10.1034/j.1399-3003.1999.14d29.x.

    PMID: 10573240BACKGROUND
  • Kozey-Keadle S, Libertine A, Lyden K, Staudenmayer J, Freedson PS. Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc. 2011 Aug;43(8):1561-7. doi: 10.1249/MSS.0b013e31820ce174.

    PMID: 21233777BACKGROUND
  • Legge BJ, Banister EW. The Astrand-Ryhming nomogram revisited. J Appl Physiol (1985). 1986 Sep;61(3):1203-9. doi: 10.1152/jappl.1986.61.3.1203.

    PMID: 3759759BACKGROUND
  • Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback. 2000 Sep;25(3):177-91. doi: 10.1023/a:1009554825745.

    PMID: 10999236BACKGROUND
  • Lum LC. Hyperventilation and anxiety state. J R Soc Med. 1981 Jan;74(1):1-4. doi: 10.1177/014107688107400101. No abstract available.

    PMID: 6780688BACKGROUND
  • Lyden K, Kozey Keadle SL, Staudenmayer JW, Freedson PS. Validity of two wearable monitors to estimate breaks from sedentary time. Med Sci Sports Exerc. 2012 Nov;44(11):2243-52. doi: 10.1249/MSS.0b013e318260c477.

    PMID: 22648343BACKGROUND
  • Macsween A. The reliability and validity of the Astrand nomogram and linear extrapolation for deriving VO2max from submaximal exercise data. J Sports Med Phys Fitness. 2001 Sep;41(3):312-7.

    PMID: 11533560BACKGROUND
  • Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, Troiano RP. Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidemiol. 2008 Apr 1;167(7):875-81. doi: 10.1093/aje/kwm390. Epub 2008 Feb 25.

    PMID: 18303006BACKGROUND
  • McConnell AK, Copestake AJ. Maximum static respiratory pressures in healthy elderly men and women: issues of reproducibility and interpretation. Respiration. 1999;66(3):251-8. doi: 10.1159/000029386.

    PMID: 10364742BACKGROUND
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

    PMID: 16055882BACKGROUND
  • Mitchell AJ, Bacon CJ, Moran RW. Reliability and Determinants of Self-Evaluation of Breathing Questionnaire (SEBQ) Score: A Symptoms-Based Measure of Dysfunctional Breathing. Appl Psychophysiol Biofeedback. 2016 Mar;41(1):111-20. doi: 10.1007/s10484-015-9316-7.

    PMID: 26400252BACKGROUND
  • Murias JM, Kowalchuk JM, Paterson DH. Speeding of VO2 kinetics with endurance training in old and young men is associated with improved matching of local O2 delivery to muscle O2 utilization. J Appl Physiol (1985). 2010 Apr;108(4):913-22. doi: 10.1152/japplphysiol.01355.2009. Epub 2010 Feb 11.

    PMID: 20150562BACKGROUND
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5-40. No abstract available.

    PMID: 8499054BACKGROUND
  • RAHN H, OTIS AB, et al. The pressure-volume diagram of the thorax and lung. Am J Physiol. 1946;146(2):161-78. doi: 10.1152/ajplegacy.1946.146.2.161. No abstract available.

    PMID: 20982947BACKGROUND
  • Sclauser Pessoa IM, Franco Parreira V, Fregonezi GA, Sheel AW, Chung F, Reid WD. Reference values for maximal inspiratory pressure: a systematic review. Can Respir J. 2014 Jan-Feb;21(1):43-50. doi: 10.1155/2014/982374. Epub 2013 Oct 17.

    PMID: 24137574BACKGROUND
  • Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J. 2010 Jul;36(1):12-9. doi: 10.1183/09031936.00143209.

    PMID: 20595163BACKGROUND
  • Volianitis S, McConnell AK, Jones DA. Assessment of maximum inspiratory pressure. Prior submaximal respiratory muscle activity ('warm-up') enhances maximum inspiratory activity and attenuates the learning effect of repeated measurement. Respiration. 2001;68(1):22-7. doi: 10.1159/000050458.

    PMID: 11223726BACKGROUND
  • Warburton CJ, Jack S. Can you diagnose hyperventilation? Chron Respir Dis. 2006;3(3):113-5. doi: 10.1191/1479972306cd116ed. No abstract available.

    PMID: 16916004BACKGROUND
  • Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available.

    PMID: 11124729BACKGROUND
  • Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 Nov;51(11):903-12. doi: 10.1016/s0895-4356(98)00081-x.

    PMID: 9817107BACKGROUND
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PMID: 1593914BACKGROUND
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

    PMID: 6880820BACKGROUND

MeSH Terms

Conditions

Respiration DisordersDyspnea

Interventions

DemographyBody HeightWeights and MeasuresAgingSex4-amino-4'-hydroxylaminodiphenylsulfonePatient Health QuestionnaireExercise TestCalorimetry, IndirectRespiratory Function Tests

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Population CharacteristicsEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthBody SizeBody Weights and MeasuresBody ConstitutionPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisPhysical Appearance, BodyAnthropometryInvestigative TechniquesPhysiological PhenomenaGrowthGrowth and DevelopmentReproductive Physiological PhenomenaReproductive and Urinary Physiological PhenomenaSurveys and QuestionnairesData CollectionEpidemiologic MethodsPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques, Respiratory SystemErgometryCalorimetryChemistry Techniques, Analytical

Study Officials

  • Panagiota Smyrni, Dr

    Brunel University London

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ms Lais Silva Vidotto

Study Record Dates

First Submitted

January 30, 2017

First Posted

February 6, 2017

Study Start

August 8, 2020

Primary Completion

April 30, 2021

Study Completion

May 30, 2021

Last Updated

July 8, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations